Ultrasis

Ultrasis Group Plc (LSE: ULT)is a healthcare company based in the United Kingdom which develops computerised healthcare products based on Cognitive Behavioural Therapy (CBT). The company’s products cover stress, anxiety and depression problems. One of the company's products has been recommended by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for all people with mild or moderate depression. The company secured a £5 million refinancing deal with shareholder Paul Bell in December 2014.

Ultrasis

Ultrasis Group Plc (LSE: ULT)is a healthcare company based in the United Kingdom which develops computerised healthcare products based on Cognitive Behavioural Therapy (CBT). The company’s products cover stress, anxiety and depression problems. One of the company's products has been recommended by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for all people with mild or moderate depression. The company secured a £5 million refinancing deal with shareholder Paul Bell in December 2014.